ONEBIO LABS / RESEARCH INFORMATION
NAD+
Research Coenzyme | Nicotinamide Adenine Dinucleotide
Technical specifications
| Full name | Nicotinamide adenine dinucleotide, oxidised form |
|---|---|
| Abbreviation | NAD+ |
| Classification | Redox coenzyme / nucleotide-derived cofactor |
| Form | Refer to product-specific documentation |
| Identity / purity | Refer to batch-specific COA |
| Purity / testing | Refer to product-specific batch COA / analytical documentation |
| Intended use | Laboratory and research purposes only |
NAD+ is not a peptide. Exact salt form, hydration state, molecular weight and purity should match the batch documentation.
01 / PRODUCT INFORMATION
Product description
NAD+ is a ubiquitous cellular coenzyme involved in redox reactions and as a substrate for several enzyme families. Laboratory research examines its roles in energy metabolism, mitochondrial function, DNA-associated signalling and cellular homeostasis.
02 / RESEARCH CONTEXT
Research overview
Research areas: Redox biology; mitochondrial metabolism; sirtuin and PARP pathways; cellular energy homeostasis.
03 / PRODUCT INFORMATION
ONE BIOLABS quality
ONE BIOLABS provides research products with product information and available batch documentation where applicable. Batch-specific identity, purity, concentration, salt form, testing and manufacturing claims should be stated only where supported by the applicable Certificate of Analysis or other analytical documentation.
04 / STORAGE
Refrigerate at 2–8°C
Unless the product-specific label or Certificate of Analysis states otherwise, store refrigerated at 2–8°C, protected from direct light, excessive heat and moisture. Keep the container securely closed. Product-specific storage instructions and stability data should take precedence.
Important notice
FOR RESEARCH PURPOSES ONLY. This product information is intended for laboratory and research reference. Products described in this document are not intended for human consumption, self-administration, diagnosis, treatment, prevention or cure of disease unless supplied as an appropriately authorised medicinal product through lawful channels. No dosage, administration or therapeutic guidance is provided.
Research findings, especially preclinical findings, should not be interpreted as proof of human safety or efficacy.
Reviews
There are no reviews yet.